Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
America Great HealthAAGH EV-to-FCF is -12.39 as of Jul. 24, 2026. The stock has 4 warning signs investors should review. Among 340 Biotechnology companies, America Great Health ranks worse than 294117.35% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, America Great Health's Enterprise Value is $5.06 Mil.
America Great Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.41 Mil. Therefore, America Great Health's EV-to-FCF for today is -12.39.
The historical rank and industry rank for America Great Health's EV-to-FCF or its related term are showing as below:
AAGH'
s EV-to-FCF Range Over the Past 10 Years
Min: -12.39 Med: 0 Max: 0
Current: -12.39
AAGH's EV-to-FCF is ranked worse than 100% of 340
companies
in the Biotechnology industry
Industry Median: 14.79
vs AAGH: -12.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
America Great Health (OTCPK:AAGH) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
America Great Health's PE Ratio (TTM) for today is calculated as:
America Great Health's share price for today is $0.0001.
America Great Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
America Great Health EV-to-FCF Related Terms
America Great Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for America Great Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, America Great Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
America Great Health EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, America Great Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where America Great Health's EV-to-FCF falls into.
America Great Health's current Enterprise Value is $5.06 Mil.
America Great Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
America Great Health (AAGH) has a EV-to-FCF of -12.39 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on America Great Health and its competitors. According to the industry distribution chart, America Great Health ranks #999999 out of 340 companies in the Biotechnology industry.
Is America Great Health's EV-to-FCF too high?
America Great Health's current EV-to-FCF is -12.39. Based on the distribution chart, America Great Health ranks #999999 out of 340 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does America Great Health's EV-to-FCF compare to ADTX and PKTX?
According to the Biotechnology industry distribution chart, America Great Health ranks #999999 out of 340 companies for EV-to-FCF. This places America Great Health in the lower half of its industry. The industry median EV-to-FCF is 14.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.79, based on 340 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on America Great Health and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. America Great Health's current EV-to-FCF is -12.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is America Great Health stock overvalued right now?
America Great Health (AAGH) has a current EV-to-FCF of -12.39. The current EV-to-FCF is -12.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For America Great Health (AAGH), the current EV-to-FCF is -12.39 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AAGH has been successfully added to your 
